We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Grassley Questions Objectivity of FDA Drug Safety Board
Grassley Questions Objectivity of FDA Drug Safety Board
June 10, 2005
Senate Finance Committee Chairman Chuck Grassley (R-Iowa) has joined the ranks of critics questioning the composition of the FDA’s newly formed Drug Safety Oversight Board (DSB).